PeptideDB

Hippuric acid-d5 (Hippuric acid-d5; 2-Benzamidoacetic acid-d5) 53518-98-2

Hippuric acid-d5 (Hippuric acid-d5; 2-Benzamidoacetic acid-d5) 53518-98-2

CAS No.: 53518-98-2

Hippuric acid-d5 is the deuterated form of Hippuric acid. Hippuric Acid (2-Benzamidoacetic acid) is an acylglycine produ
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Hippuric acid-d5 is the deuterated form of Hippuric acid. Hippuric Acid (2-Benzamidoacetic acid) is an acylglycine produced by the combination of benzoic acid and glycine. It is a normal urine component and comes from the metabolism of aromatic compounds in food.

Physicochemical Properties


Molecular Formula C9H4D5NO3
Molecular Weight 184.20
Exact Mass 184.089
CAS # 53518-98-2
Related CAS # Hippuric acid;495-69-2
PubChem CID 101624378
Appearance White to off-white solid powder
Density 1.2±0.1 g/cm3
Boiling Point 379.6±44.0 °C at 760 mmHg
Flash Point 183.4±28.4 °C
Vapour Pressure 0.0±0.9 mmHg at 25°C
Index of Refraction 1.561
LogP 1.3
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 3
Heavy Atom Count 13
Complexity 197
Defined Atom Stereocenter Count 0
SMILES

[2H]C1=C(C(=C(C(=C1[2H])[2H])C(=O)NCC(=O)O)[2H])[2H]

InChi Key QIAFMBKCNZACKA-RALIUCGRSA-N
InChi Code

InChI=1S/C9H9NO3/c11-8(12)6-10-9(13)7-4-2-1-3-5-7/h1-5H,6H2,(H,10,13)(H,11,12)/i1D,2D,3D,4D,5D
Chemical Name

2-[(2,3,4,5,6-pentadeuteriobenzoyl)amino]acetic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro Drug compounds have included stable heavy isotopes of carbon, hydrogen, and other elements, mostly as quantitative tracers while the drugs were being developed. Because deuteration may have an effect on a drug's pharmacokinetics and metabolic properties, it is a cause for concern [1].
References

[1]. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

[2]. Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure. Semin Nephrol. 1996 May;16(3):167-82.


Solubility Data


Solubility (In Vitro) DMSO: 250 mg/mL (1357.22 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (11.29 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.08 mg/mL (11.29 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.08 mg/mL (11.29 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 5.4289 mL 27.1444 mL 54.2888 mL
5 mM 1.0858 mL 5.4289 mL 10.8578 mL
10 mM 0.5429 mL 2.7144 mL 5.4289 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.